COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES

RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences

November 04, 2025



« back to news page